HCA Healthcare Inc. (HCA)
HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2024 EPS View
HCA Healthcare (HCA) increases its 2024 EPS in the range of $21.60-$22.8, the midpoint implying growth of 17% from the 2023 figure.
Compared to Estimates, HCA (HCA) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for HCA (HCA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
HCA Healthcare (HCA) Surpasses Q2 Earnings and Revenue Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $5.50 per share, beating the Zacks Consensus Estimate of $4.97 per share. This compares to earnings of $4.29 per share a year ago.
HCA's stock surges as hospital operator's quarterly results top expectations
Hospital giant raises full-year guidance amid growth in admissions, inpatient surgeries
HCA Healthcare raises annual profit forecast on strong demand for medical care
HCA Healthcare raised its annual profit forecast on Tuesday, after beating Wall Street estimates for quarterly earnings, sending shares of the hospital operator up nearly 7% before the bell.
Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?
Here is how HCA Healthcare (HCA) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.
HCA Healthcare Q2 Earnings Preview: Cost And Margin In Focus
HCA Healthcare, Inc. will report earnings on Tuesday, July 23rd. I expect HCA to have a strong quarter based on reaffirmed guidance, industry trends, and consensus revisions upward. Multiple valuation methods signal HCA is fairly priced, while industry trends suggest balanced upside and downside. I continue to rate HCA a hold.
Can HCA Healthcare (HCA) Beat Q2 Earnings on Growing Admissions?
HCA Healthcare's (HCA) second-quarter earnings are likely to benefit from improved admissions and payer mix, partially offset by rising operating expenses.
HCA Healthcare (HCA) Reports Next Week: Wall Street Expects Earnings Growth
HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever
These healthcare businesses are booming. Vertex Pharmaceuticals is raking in approvals, cash, and profits.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
